These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11904167)

  • 1. Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues.
    Fezza F; Bisogno T; Minassi A; Appendino G; Mechoulam R; Di Marzo V
    FEBS Lett; 2002 Feb; 513(2-3):294-8. PubMed ID: 11904167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry.
    Richardson D; Ortori CA; Chapman V; Kendall DA; Barrett DA
    Anal Biochem; 2007 Jan; 360(2):216-26. PubMed ID: 17141174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
    Laine K; Järvinen K; Mechoulam R; Breuer A; Järvinen T
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3216-22. PubMed ID: 12356827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
    Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors.
    Appendino G; Ligresti A; Minassi A; Daddario N; Bisogno T; Di Marzo V
    Bioorg Med Chem Lett; 2003 Jan; 13(1):43-6. PubMed ID: 12467613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.
    Bisogno T; Berrendero F; Ambrosino G; Cebeira M; Ramos JA; Fernandez-Ruiz JJ; Di Marzo V
    Biochem Biophys Res Commun; 1999 Mar; 256(2):377-80. PubMed ID: 10079192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.
    Hanus L; Abu-Lafi S; Fride E; Breuer A; Vogel Z; Shalev DE; Kustanovich I; Mechoulam R
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3662-5. PubMed ID: 11259648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain.
    Viganò D; Grazia Cascio M; Rubino T; Fezza F; Vaccani A; Di Marzo V; Parolaro D
    Neuropsychopharmacology; 2003 Jun; 28(6):1160-7. PubMed ID: 12637958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS.
    Williams J; Wood J; Pandarinathan L; Karanian DA; Bahr BA; Vouros P; Makriyannis A
    Anal Chem; 2007 Aug; 79(15):5582-93. PubMed ID: 17600384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus.
    Venderova K; Brown TM; Brotchie JM
    Exp Neurol; 2005 Jul; 194(1):284-7. PubMed ID: 15899265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether.
    Juntunen J; Vepsäläinen J; Niemi R; Laine K; Järvinen T
    J Med Chem; 2003 Nov; 46(23):5083-6. PubMed ID: 14584958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.
    González S; Cascio MG; Fernández-Ruiz J; Fezza F; Di Marzo V; Ramos JA
    Brain Res; 2002 Nov; 954(1):73-81. PubMed ID: 12393235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species.
    Oka S; Tsuchie A; Tokumura A; Muramatsu M; Suhara Y; Takayama H; Waku K; Sugiura T
    J Neurochem; 2003 Jun; 85(6):1374-81. PubMed ID: 12787057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatographic-mass spectrometric measurement of the endogenous cannabinoid 2-arachidonylglycerol in the spinal cord and peripheral nervous system.
    Huang SM; Strangman NM; Walker JM
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1098-102. PubMed ID: 11189199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404.
    Hájos N; Kathuria S; Dinh T; Piomelli D; Freund TF
    Eur J Neurosci; 2004 Jun; 19(11):2991-6. PubMed ID: 15182306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain monoglyceride lipase participating in endocannabinoid inactivation.
    Dinh TP; Carpenter D; Leslie FM; Freund TF; Katona I; Sensi SL; Kathuria S; Piomelli D
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10819-24. PubMed ID: 12136125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols.
    Schmid PC; Schwartz KD; Smith CN; Krebsbach RJ; Berdyshev EV; Schmid HH
    Chem Phys Lipids; 2000 Feb; 104(2):185-91. PubMed ID: 10669310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids in the central nervous system--an overview.
    Fride E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
    Giuffrida A; Beltramo M; Piomelli D
    J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.